Vincere Biosciences, Inc
- Biotech or pharma, therapeutic R&D
Vincere is advancing disease-modifying small molecules for Parkinson’s by boosting mitophagy. Currently in the IND-enabling phase, our highly potent and selective USP30 inhibitors are nearing the ideal point for partnering into human clinical trials.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}